Moreover, the CD26 expression on NSCLC cells was associated with the expression of several antigens involved in the tumor suppression (such as the fibroblast-activating protein or the CD44 antigen), confirming its role as a tumor suppressor in this malignancy [14]. This evidence concerns the gene CD44 and neoplasm.